These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 19013060

  • 1. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies.
    Zhu L, Ma J, Jia N, Zhao Y, Shen H.
    Colloids Surf B Biointerfaces; 2009 Jan 01; 68(1):1-6. PubMed ID: 19013060
    [Abstract] [Full Text] [Related]

  • 2. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F, Sun J, Zhu H, Wen X, Lin C, Shi D.
    Colloids Surf B Biointerfaces; 2011 Nov 01; 88(1):58-62. PubMed ID: 21764271
    [Abstract] [Full Text] [Related]

  • 3. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro.
    Ge Y, Zhang Y, Xia J, Ma M, He S, Nie F, Gu N.
    Colloids Surf B Biointerfaces; 2009 Oct 15; 73(2):294-301. PubMed ID: 19564099
    [Abstract] [Full Text] [Related]

  • 4. [Preparation and characterization of biotinylated chitosan nanoparticles].
    Yao Q, Hou SX, Zhang X, Zhao G, Gou XJ, You JZ.
    Yao Xue Xue Bao; 2007 May 15; 42(5):557-61. PubMed ID: 17703783
    [Abstract] [Full Text] [Related]

  • 5. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
    Yan C, Chen D, Gu J, Qin J.
    J Pharm Pharmacol; 2006 Sep 15; 58(9):1177-81. PubMed ID: 16945175
    [Abstract] [Full Text] [Related]

  • 6. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications.
    Kettering M, Zorn H, Bremer-Streck S, Oehring H, Zeisberger M, Bergemann C, Hergt R, Halbhuber KJ, Kaiser WA, Hilger I.
    Phys Med Biol; 2009 Sep 07; 54(17):5109-21. PubMed ID: 19661569
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells.
    Mi FL, Wu YY, Chiu YL, Chen MC, Sung HW, Yu SH, Shyu SS, Huang MF.
    Biomacromolecules; 2007 Mar 07; 8(3):892-8. PubMed ID: 17316043
    [Abstract] [Full Text] [Related]

  • 8. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E, Sarisozen C, Esendağli G, Doğan AL, Aktaş Y, Sen M, Mungan NA.
    Int J Pharm; 2009 Apr 17; 371(1-2):170-6. PubMed ID: 19135514
    [Abstract] [Full Text] [Related]

  • 9. Suspension of Fe(3)O(4) nanoparticles stabilized by chitosan and o-carboxymethylchitosan.
    Zhu A, Yuan L, Liao T.
    Int J Pharm; 2008 Feb 28; 350(1-2):361-8. PubMed ID: 17931808
    [Abstract] [Full Text] [Related]

  • 10. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
    Cai L, Niu G, Hu Z, Jin W, Wang J, Sun L.
    J Drug Target; 2009 Apr 28; 17(3):200-6. PubMed ID: 19558359
    [Abstract] [Full Text] [Related]

  • 11. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M, Raj V, Al-Arfaj AA, Murugan AM.
    Int J Pharm; 2013 Sep 10; 453(2):514-22. PubMed ID: 23796828
    [Abstract] [Full Text] [Related]

  • 12. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
    Li FR, Yan WH, Guo YH, Qi H, Zhou HX.
    Int J Hyperthermia; 2009 Aug 10; 25(5):383-91. PubMed ID: 19391033
    [Abstract] [Full Text] [Related]

  • 13. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
    Zhang Y, Li J, Lang M, Tang X, Li L, Shen X.
    J Colloid Interface Sci; 2011 Feb 01; 354(1):202-9. PubMed ID: 21094493
    [Abstract] [Full Text] [Related]

  • 14. Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia.
    Kim DH, Kim KN, Kim KM, Lee YK.
    J Biomed Mater Res A; 2009 Jan 01; 88(1):1-11. PubMed ID: 18257079
    [Abstract] [Full Text] [Related]

  • 15. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM, Li YJ, Qiu LY, Jin Y.
    J Pharm Pharmacol; 2009 Jun 01; 61(6):713-9. PubMed ID: 19505361
    [Abstract] [Full Text] [Related]

  • 16. Multifunctional carboxymethyl cellulose-based magnetic nanovector as a theragnostic system for folate receptor targeted chemotherapy, imaging, and hyperthermia against cancer.
    Sivakumar B, Aswathy RG, Nagaoka Y, Suzuki M, Fukuda T, Yoshida Y, Maekawa T, Sakthikumar DN.
    Langmuir; 2013 Mar 12; 29(10):3453-66. PubMed ID: 23409925
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
    Zhou H, Yu W, Guo X, Liu X, Li N, Zhang Y, Ma X.
    Biomacromolecules; 2010 Dec 13; 11(12):3480-6. PubMed ID: 21028798
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles.
    Liang J, Li F, Fang Y, Yang W, An X, Zhao L, Xin Z, Cao L, Hu Q.
    Colloids Surf B Biointerfaces; 2011 Feb 01; 82(2):297-301. PubMed ID: 20888740
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.